OTTAWA, Jan. 5, 2016 /CNW/ - Annidis Corporation (TSX Venture: RHA) ("Annidis" or the "Company") announces that it has mutually agreed to terminate the employment agreement with its President Mr. Nick Ribaric effective January 1, 2016. Mr. Michael Crowley, Chief Executive Officer of Annidis, assumes the role of President of the Company effective January 1, 2016 on an interim basis.
Annidis wishes to extend its sincerest thanks Mr. Ribaric for his commitment and his numerous contributions to the Company and wishes him the very best in his future endeavours.
Mr. Ribaric remains a director of Annidis.
About Annidis Corporation
Annidis (TSX-V: RHA) has developed and is marketing a new imaging platform technology based on Multi-Spectral Imaging (MSI). This new technology is opening a new frontier in disease identification and its management. The Annidis MSI technology allows eye-care professionals to view non-invasively the deepest areas of the eye aiding eye care professionals in the early identification and treatment of debilitating eye diseases. The Company's existing RHA 2020-U Gold, used by eye care professionals as a broad based tool for detecting early-onset of eye related diseases such as Dry AMD, has a potential market of over 20,000 clinics in North America.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Annidis Corporation
For further information: Michael Crowley, CEO, Annidis Corporation, 519-859-7439, firstname.lastname@example.org; Babak Pedram, Investor Relations, Virtus Advisory Group Inc., 416-995-8651, email@example.com